All News

Medication adherence can be greatly improved when pharmacists meet with patients and synchronize their meds.

Last week, President Obama signed the Drug Quality and Security Act into law, providing FDA with the authority and responsibility to regulate “outsourcing facilities,” compounders that make large volumes of compounded drugs without individual prescriptions. The American Pharmacists Association (APhA) supported and helped with the drafting of the legislation.

Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.

FDA has requested label and packaging changes for certain over-the-counter topical antiseptic products to decrease the risk of infections from these products, which in rare cases have resulted in deaths.

FDA is warning healthcare professionals of the rare but serious risk of heart attack and death with use of cardiac nuclear stress test agents regadenoson (Lexiscan) and adenosine (Adenoscan).

Pregnant women exposed to environmental phthalates are at an elevated risk of preterm delivery, according to a recent study in JAMA Pediatrics.

Sandoz has announced the U.S. launch of an authorized generic version of PharmaDerm’s Solaraze Gel (diclofenac 3% gel), which generated $92 million in 2012.

Changing the infusion site of specialty drugs can lower costs for patients with cancer, rheumatoid arthritis, multiple sclerosis, and other complex diseases, according to the 2013 Specialty Trend Management Insights Report, released by CVS Caremark.

Congressional action to tighten regulations for compounding pharmacies will not prevent another tragedy such as last year’s fungal meningitis outbreak, according to the Academy of Managed Care Pharmacy.

Total global spending on prescription medicines will increase by between $205 and $235 billion from 2012 through 2017, reaching more than $1 trillion in 2017, according to a study released Nov. 19.

Independent community pharmacists who want to sell or expand their business can consult with a new network of resources established by AmerisourceBergen Corp.

Improper dosing of chemotherapy in IV bags recently caused a problem among a group of patients in Canada, so the Institute for Safe Medication Practices (ISMP) is cautioning healthcare practitioners about chemotherapy dosing.

FDA has approved the supplemental New Drug Application for tofacitinib citrate (Xeljanz, Pfizer) to include additional patient-reported outcomes data on the label.

The Michigan Senate has approved a bill that would allow medical marijuana to be dispensed by pharmacies throughout the state. However, the vote by the Michigan senators is merely symbolic, as FDA would have to reclassify marijuana as Schedule II to allow such dispensing.

Collaborative care with pharmacists helped to boost medication adherence in patients with acute coronary syndrome after hospital discharge. However, after 12- month follow-up, the proportion of patients who achieved blood pressure and LDL-cholesterol goals were not significantly different from patients treated under usual care, according to a recent study published online for JAMA Internal Medicine.

FDA has approved ibrutinib (Imbruvica, Pharmacyclics and Janssen) to treat patients with mantle cell lymphoma (MCL), a rare and aggressive type of blood cancer. It is the second drug with breakthrough therapy designation to receive FDA approval.

Medication adherence rates for HIV patients with associated comorbidities such as mental illness was higher for patients using Walgreens HIV-specialized pharmacies than for patients using the chain’s other retail pharmacies, according to two recently released studies.

Lurasidone HCl (Latuda) reduces depressive symptoms in adult patients with bipolar depression when used as monotherapy and adjunctive therapy to lithium or valproate. This flexibility is important given the multiple unmet needs of patients with bipolar depression, according to two phase 3 studies published recently in The American Journal of Psychiatry.

The U.S. Senate has voted overwhelmingly to adopt tighter regulations for compounding pharmacies and to create a national system that tracks prescription drugs from manufacturers to pharmacies.

Health Mart has launched a marketing support program to help its pharmacy owners attract new customers and find additional revenue sources.

Walgreens has donated $100,000 to the American Red Cross for Typhoon Haiyan disaster-relief efforts.

When pharmacists manage drug therapy for physicians, diabetes patients see a significant improvement in key measures.

The U.S. healthcare system, broken even before the Affordable Care Act, needs a team-based care approach that’s more focused on patients, as well as an increased political effort to advance healthcare, according to researchers speaking at a JAMA media briefing at the National Press Club in Washington, D.C., on November 12.

Statin therapy is now recommended for approximately 33 million Americans who don’t have cardiovascular disease (CVD), but have an estimated 10-year CV risk of 7.5% or higher. These individuals also have LDL cholesterol between 70 mg/dL and 189 mg/dL, according to new guidelines issued Nov. 12 by the American College of Cardiology and the American Heart Association.

CMS' new rules for fees, mail order, and delivery of diabetes testing products have created big challenges for patients and the community pharmacists who used to deliver their supplies.

Prescribers treating obese and overweight patients with diabetes now have two new treatment options to consider.

In the wake of last year's fungal meningitis tragedy, the Specialty Sterile Pharmaceutical Society brings a new voice to an industry under fire.